Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer

We show that the lipidomic profile of CRC tumours exhibits a distinct pro-inflammatory bias with a deficiency of endogenous resolving mediators secondary to defective lipid class switching. These observations pave the way for 'resolution medicine', a novel therapeutic approach for inducing or providing resolvins to mitigate the chronic inflammation driving cancer growth and progression.

Authors

Institutions

Publication Details

Journal
Gut
Published
2024-12-10
DOI
https://doi.org/10.1136/gutjnl-2024-332535
Citations
31
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
8.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer

Mingli Yang, Jetsen A. Rodriguez-Silva, Ramani Soundararajan, Gunjan Upadhyay et al.
31 citations
Gut
Cancer, Lipids, and Metabolism
8.84
article

Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer

Mingli Yang, Jetsen A. Rodriguez-Silva, Ramani Soundararajan, Gunjan Upadhyay, Divyavani Gowda, Carolina Martinez, Timothy J Yeatman, Shu‐Ping Hui, Ashley J. Alden, Paul M. Cavallaro, Robert J. Coffey, Ganesh V. Halade, Michelle M. Maurin, Andreas Karachristos, Michael Nebozhyn, Michael J. Schell, Matthew L. Anderson, Andrey Loboda, Lance Pflieger, Warren Jackson Pledger, Jorge Marcet, Allen P. Chudzinski, Heiman Wang, Timothy M. Nywening, Punith M. Sundaraswamy, Domenico Coppola, Robert David Bennett, Siddabasave Gowda B. Gowda, Noah Jhad Levine
article en
31 citations

Abstract

We show that the lipidomic profile of CRC tumours exhibits a distinct pro-inflammatory bias with a deficiency of endogenous resolving mediators secondary to defective lipid class switching. These observations pave the way for 'resolution medicine', a novel therapeutic approach for inducing or providing resolvins to mitigate the chronic inflammation driving cancer growth and progression.

GutVol. 74(4)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Buck Institute for Research on Aging (US), Hokkaido University (JP), University of South Florida (US), Tampa General Hospital (US), Moffitt Cancer Center (US), Florida Digestive Health Specialists (US), Vanderbilt University Medical Center (US)
National Institute for Health and Care Research, Israel National Institute for Health Policy Research, National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 1%
Cancer, Lipids, and Metabolism
8.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.